These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34438319)

  • 21. Generation of homozygous Na
    Maurer W; Hartmann N; Argyriou L; Sossalla S; Streckfuss-Bömeke K
    Stem Cell Res; 2022 Apr; 60():102677. PubMed ID: 35092938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of an Induced Pluripotent Stem Cell Line with the Constitutive EGFP Reporter.
    Butterfield KT; McGrath PS; Han CM; Kogut I; Bilousova G
    Methods Mol Biol; 2020; 2155():11-21. PubMed ID: 32474864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors.
    Jin Y; Shen Y; Su X; Weintraub N; Tang Y
    J Vis Exp; 2019 Sep; (151):. PubMed ID: 31566614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of a gene edited hemophilia A patient-derived iPSC cell line, YCMi001-B-1, by targeted insertion of coagulation factor FVIII using CRISPR/Cas9.
    Sung JJ; Park S; Choi SH; Kim J; Cho MS; Kim DW
    Stem Cell Res; 2020 Oct; 48():101948. PubMed ID: 32798916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome Editing in Induced Pluripotent Stem Cells using CRISPR/Cas9.
    Ben Jehuda R; Shemer Y; Binah O
    Stem Cell Rev Rep; 2018 Jun; 14(3):323-336. PubMed ID: 29623532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of a human induced pluripotent stem cell line with Cas9 driven by Tet-on operator via AAVS1 safe harbor gene-editing.
    Ding Y; Wang L; Ji W; Chen Z; Wang D; Chen C; Tong H; Han Z; Niu C; Chu M; Huang J; Guo X
    Stem Cell Res; 2020 Dec; 49():102064. PubMed ID: 33207306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rhesus iPSC Safe Harbor Gene-Editing Platform for Stable Expression of Transgenes in Differentiated Cells of All Germ Layers.
    Hong SG; Yada RC; Choi K; Carpentier A; Liang TJ; Merling RK; Sweeney CL; Malech HL; Jung M; Corat MAF; AlJanahi AA; Lin Y; Liu H; Tunc I; Wang X; Palisoc M; Pittaluga S; Boehm M; Winkler T; Zou J; Dunbar CE
    Mol Ther; 2017 Jan; 25(1):44-53. PubMed ID: 28129126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of a MIR5004 knockout cell line from human induced pluripotent stem cells by CRISPR/Cas9 gene editing.
    Gulimiheranmu M; Li S; Zhou J
    Stem Cell Res; 2022 Jul; 62():102805. PubMed ID: 35576811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CRISPR/Cas9 editing to generate a heterozygous COL2A1 p.G1170S human chondrodysplasia iPSC line, MCRIi019-A-2, in a control iPSC line, MCRIi019-A.
    Kung LHW; Sampurno L; Yammine KM; Graham A; McDonald P; Bateman JF; Shoulders MD; Lamandé SR
    Stem Cell Res; 2020 Oct; 48():101962. PubMed ID: 33002832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of a ZEB2 deficient human iPSC line (KICRi002A-4).
    Schuster J; Fatima A; Papadopoulos N; de Guidi C; Sobol M; Dahl N
    Stem Cell Res; 2024 Oct; 80():103521. PubMed ID: 39121652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of a WWTR1 mutation induced pluripotent stem cell line, MUSIi012-A-1, using CRISPR/Cas9.
    Lorthongpanich C; Jiamvoraphong N; Supakun P; Damkham N; Terbto P; Waeteekul S; U-Pratya Y; Laowtammathron C; Issaragrisil S
    Stem Cell Res; 2019 Dec; 41():101634. PubMed ID: 31677525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of a homozygous ARHGAP11B knockout hiPSC line by CRISPR/Cas9 system.
    Liu Y; Jin Y; Chen T; Wu Y; Peng X; Li W; Wei S; Chen M; Zou Q; Guo S; Xu J; Tang C; Zhou X
    Stem Cell Res; 2022 May; 61():102764. PubMed ID: 35358830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentiation of primordial germ cells from induced pluripotent stem cells of primary ovarian insufficiency.
    Leng L; Tan Y; Gong F; Hu L; Ouyang Q; Zhao Y; Lu G; Lin G
    Hum Reprod; 2015 Mar; 30(3):737-48. PubMed ID: 25586786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incontinentia pigmenti: Generation of an IKBKG deficient human iPSC line (KICRi002-A-1) on a 46,XY background using CRISPR/Cas9.
    Fatima A; Schuster J; Akram T; González CM; Sobol M; Hoeber J; Dahl N
    Stem Cell Res; 2020 Apr; 44():101739. PubMed ID: 32126327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prime editor efficiently repaired human induced pluripotent stem cells with AR gene mutation (c.2710G > A; p. V904M).
    Sun R; Cui Y; Liu Z; Guo J; Zhang X; Zhu P; Sha J; Yang X; Yuan Y
    Stem Cell Res; 2023 Jun; 69():103102. PubMed ID: 37148822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of a gene corrected human isogenic IBMS-iPSC-014-C from polycystic-kidney-disease induced pluripotent stem cell line using CRISPR/Cas9.
    Liu CL; Huang CY; Chen HC; Lu HE; Hsieh PCH; Lee JJ
    Stem Cell Res; 2020 May; 45():101784. PubMed ID: 32361310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of a gene corrected human isogenic iPSC line (CPGHi001-A-1) from a hearing loss patient with the TMC1 p.M418K mutation using CRISPR/Cas9.
    Wang H; Luo Y; Li J; Guan J; Yang S; Wang Q
    Stem Cell Res; 2022 Apr; 60():102736. PubMed ID: 35247837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of human induced pluripotent stem cell line carrying SCN5AC2204>T Brugada mutation (MUSli009-A-1) introduced by CRISPR/Cas9-mediated genome editing.
    Angsutararux P; Luanpitpong S; Chingsuwanrote P; Supraditaporn K; Waeteekul S; Terbto P; Lorthongpanich C; Laowtammathron C; U-Pratya Y; Issaragrisil S
    Stem Cell Res; 2019 Dec; 41():101618. PubMed ID: 31677524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of an NCS1 gene knockout human induced pluripotent stem cell line using CRISPR/Cas9.
    Maierhof SK; Schinke C; Cernoch J; Hew L; Bruske LP; Fernandez Vallone V; Fischer K; Stachelscheid H; Huehnchen P; Endres M; Diecke S; Telugu NS; Boehmerle W
    Stem Cell Res; 2023 Dec; 73():103253. PubMed ID: 37984032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of a homozygous ZBTB7A knockout human induced pluripotent stem line by CRISPR/Cas9 editing.
    Chen D; Song B; Cheng Y; Zhu L; Lu D; Liu N; Yang Y; Sun X
    Stem Cell Res; 2021 Aug; 55():102494. PubMed ID: 34403853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.